- Mechanism
- Inhibits acetylcholine release via enkephalin mimicry
- Typical research dose
- 2-10% concentration in topical formulations
- Route
- topical
- Half-life
- Unknown (topical application)
- Legal status
- Research Only / Cosmetic Ingredient
Overview
Pentapeptide-18, commonly known as Leuphasyl, is a synthetic cosmetic peptide designed to target expression wrinkles. This neuropeptide mimics the natural mechanism of enkephalins, modulating neuromuscular signaling to gently reduce muscle contractions without paralysis. Researchers study the Pentapeptide-18 peptide for its potential to smooth fine lines, particularly when combined with other anti-aging compounds like Argireline. Understanding Pentapeptide-18 benefits provides insight into non-invasive, topical alternatives to traditional neurotoxin injections.
Potential Benefits
- Expression Wrinkle Reduction: Clinical studies indicate that topical application significantly decreases the depth of wrinkles caused by facial muscle contractions (Gorouhi et al., 2009).
- Synergistic Anti-Aging Effects: Research shows enhanced efficacy in reducing fine lines when combined with Acetyl Hexapeptide-8 (Argireline), offering compounded muscle-relaxing benefits.
- Non-Invasive Muscle Relaxation: It offers a topical alternative to botulinum toxin by gently attenuating muscle contraction without causing complete paralysis or stiffness.
- Skin Texture Improvement: Regular application is associated with smoother overall skin topography, reduced roughness, and a more even epidermal surface.
- High Tolerability: Studies suggest it is well-tolerated on various skin types with a significantly lower risk of irritation compared to traditional retinoids.
Side Effects
Common side effects:
- Mild skin irritation at the application site
- Localized redness or transient erythema
- Temporary itching or tingling sensation
- Dryness or flaking of the epidermis
- Minor contact dermatitis in sensitive individuals
Rare or serious side effects:
- Severe allergic contact dermatitis
- Prolonged stinging or burning sensation
- Localized swelling or edema
- Disruption of the skin barrier with overuse
Pentapeptide-18 is not FDA-approved and is intended for research purposes only. Consult a qualified healthcare provider before use.
Mechanism of Action
Enkephalin mimicry drives the primary mechanism of the Pentapeptide-18 peptide in reducing facial wrinkles. It couples to the enkephalin receptor on the outside of nerve cells, initiating a biochemical cascade that lowers the excitability of the neuron.
Neurotransmitter inhibition occurs as this receptor activation decreases the influx of calcium ions, subsequently limiting the release of acetylcholine into the synaptic cleft. Consequently, the muscle contraction is attenuated, leading to a visible reduction in dynamic skin folds and expression lines.
Origin & History
Synthetic development of Pentapeptide-18 was pioneered by Lipotec, a Spanish cosmetic active ingredient manufacturer, under the trade name Leuphasyl. It was specifically engineered using rational drug design to mimic natural enkephalins and provide a topical solution for expression wrinkles.
Regulatory status categorizes this compound strictly as a cosmetic ingredient rather than a pharmaceutical drug. It remains widely available in over-the-counter anti-aging formulations and is designated globally for research and topical cosmetic use only.